Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?
Vanessa Costa Miranda
No relevant relationships to disclose
Luiza Dib-Faria
No relevant relationships to disclose
Maria Ignez Freitas Melro Braghiroli
No relevant relationships to disclose
Jorge Sabbaga
No relevant relationships to disclose
Daniel Fernandes Saragiotto
No relevant relationships to disclose
Gilberto Castro
No relevant relationships to disclose
Paulo M. Hoff
No relevant relationships to disclose
Rachel Riechelmann
No relevant relationships to disclose